Pathfinder Cell Therapy's goodwill is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Pathfinder Cell Therapy (PFND) currently reports a goodwill of $0 as of September 2015. In the prior-year period, the figure was $0. Use the charts on this page to explore Pathfinder Cell Therapy's goodwill history and peer comparisons.
Pathfinder Cell Therapy's goodwill changed from $0 to $0 (period ending September 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Pathfinder Cell Therapy reported $0 in goodwill as of September 2015. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pathfinder Cell Therapy, and consider following PFND for alerts when major investors trade the stock.
Pathfinder Cell Therapy is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PFND with unrelated industries.